Literature DB >> 10197564

Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis.

S Yu-Poth1, G Zhao, T Etherton, M Naglak, S Jonnalagadda, P M Kris-Etherton.   

Abstract

BACKGROUND: Plasma lipid and lipoprotein responses have been variable in dietary intervention studies.
OBJECTIVE: The objective of this study was to evaluate the effects of the National Cholesterol Education Program's Step I and Step II dietary interventions on major cardiovascular disease risk factors using meta-analysis.
DESIGN: MEDLINE was used to select 37 dietary intervention studies in free-living subjects published from 1981 to 1997.
RESULTS: Step I and Step II dietary interventions significantly decreased plasma lipids and lipoproteins. Plasma total cholesterol (TC), LDL cholesterol, triacylglycerol, and TC:HDL cholesterol decreased by 0.63 mmol/L (10%), 0.49 mmol/L (12%), 0.17 mmol/L (8%), and 0.50 (10%), respectively, in Step I intervention studies, and by 0.81 mmol/L (13%), 0.65 mmol/L (16%), 0.19 mmol/L (8%), and 0.34 (7%), respectively, in Step II intervention studies (P < 0.01 for all). HDL cholesterol decreased by 7% (P = 0.05) in response to Step II but not to Step I dietary interventions. Positive correlations between changes in dietary total and saturated fatty acids and changes in TC and LDL and HDL cholesterol were observed (r = 0.59, 0.61, and 0.46, respectively; P < 0.001). Multiple regression analyses showed that for every 1% decrease in energy consumed as dietary saturated fatty acid, TC decreased by 0.056 mmol/L and LDL cholesterol by 0.05 mmol/L. Moreover, for every 1-kg decrease in body weight, triacylglycerol decreased by 0.011 mmol/L and HDL cholesterol increased by 0.011 mmol/L. Exercise resulted in greater decreases in TC, LDL cholesterol, and triacylglycerol and prevented the decrease in HDL cholesterol associated with low-fat diets.
CONCLUSION: Step I and Step II dietary interventions have multiple beneficial effects on important cardiovascular disease risk factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197564     DOI: 10.1093/ajcn/69.4.632

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  94 in total

Review 1.  Beyond cholesterol lowering: deciphering the benefits of dietary intervention on cardiovascular diseases.

Authors:  V A Mustad; P M Kris-Etherton
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

2.  Lean Red Meat and Lean White Meat in the NCEP Step I Diet.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

3.  Hyperlipidemia: Part 1. Evaluation and dietary management.

Authors:  M Tanner; N Link
Journal:  West J Med       Date:  2001-10

Review 4.  New thoughts on managing obesity.

Authors:  P G Kopelman; C Grace
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 5.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 6.  Diet and exercise for weight loss: a review of current issues.

Authors:  Jeff S Volek; Jaci L Vanheest; Cassandra E Forsythe
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 7.  Diet and low-density lipoprotein particle size.

Authors:  Sophie Desroches; Benoît Lamarche
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 8.  Medications or lifestyle change with medical nutrition therapy.

Authors:  Joyce Green Pastors
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

9.  What We Know About Diet, Genes, and Dyslipidemia: Is There Potential for Translation?

Authors:  Toni I Pollin; Michael Quartuccio
Journal:  Curr Nutr Rep       Date:  2013-12

10.  Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.

Authors:  Sabita S Soedamah-Muthu; Nish Chaturvedi; John H Fuller; Monika Toeller
Journal:  Eur J Nutr       Date:  2012-12-07       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.